Abstract:There is large interest in the early diagnosis of Alzheimer's disease (AD) using machine learning. The NIH-sponsored Alzheimer's Disease Connectome Project (ADCP), a multi-center MRI, PET, and behavioral study of brain connectivity in AD, has a specific aim of accurately staging AD throughout its progression on an individual basis. It uses state-of-the-art MRI imaging techniques which allow for building reliable machine learning models. In this ongoing project, we are training models with the MRI structural brain features to separate between healthy controls and a group of AD and mild cognitive impairment (MCI) patients. Data from 12 patients (age=70.8±6.6 years, 7 males, 4 AD patients), and 20 healthy controls (age=68.9±6.2 years, 11 males), enrolled in ADCP, were analyzed. The two groups matched in age (p=0.45) and gender ratio (p=0.85). All images were acquired with 3T GE 750 scanners. T1-weighted images were acquired using a magnetization prepared gradient echo sequence (TR/TE=604ms/2.516ms, 0.8mm isotropic). Data were pre-processed using FreeSurfer-based Human Connectome Project (HCP) processing pipelines. 269 structural features were extracted, which include cortical thicknesses, surface areas, and subcortical and global volumes. They were normalized with the individual intracranial volume and then with the standardized z-score transform. 3 traditional binary classification machine learning models were trained in Matlab: support vector machine (SVM), linear discriminant analysis (LDA), and naïve Bayes (NB) classifiers. We applied a t-test based filter selection method, where only a group of features with the largest group mean differences in the training set enters the training. For performance estimation, we used leave-one-out cross validation (LOOCV) and the area-under-the-curve (AUC). SVM model classified the two groups with 90.6% accuracy (sensitivity=83.3%, specificity=95.0%, AUC=0.78, 23 features). NB model reached 84.38% (sensitivity=83.3%, specificity=85.0%, AUC=0.83, 10 features). Bilateral temporal pole volumes and right entorhinal volume were the most discriminating features. Linear traditional machine learning models were able to separate between AD/MCI patients and healthy controls with mid-80 to 90% accuracy. This is promising as it is known that non-linear, deep learning methods will outperform these traditional models given more data in the future. Building an automated model to classify Alzheimer's patients is expected to aid early diagnosis . A t-test based filter selection method was used to let only a certain number of features with the most group difference to be used in the training. SVM reached the highest LOOCV accuracy at 90.6% using 23 features. Bilateral temporal pole volumes showed the most group differences and helped machine learning separate the two groups. The volumes are noticeably reduced in MCI and AD patients compared to the healthy controls.

Classifying Alzheimer's disease and normal subjects using machine learning techniques and genetic-environmental features

Attention-based and Micro Designed EfficientNetB2 for Diagnosis of Alzheimer’s Disease

Comparative analysis of machine learning algorithms for Alzheimer's disease classification using EEG signals and genetic information

Classifying Alzheimer's disease with brain imaging and genetic data using a neural network framework

Deep Neural Network Classifier for Alzheimer’s Disease

Classification of Alzheimer’s Disease Using Conventional Machine Learning Methods with Cortical and Genetic Characteristics

Classification of Alzheimer's Disease Using Robust TabNet Neural Networks on Genetic Data.

Application of artificial neural network model in diagnosis of Alzheimer's disease

CHARACTERIZING STRUCTURAL BRAIN ALTERATIONS IN ALZHEIMER’S DISEASE PATIENTS WITH MACHINE LEARNING

An explainable machine learning based prediction model for Alzheimer's disease in China longitudinal aging study

An Alzheimers Disease Related Genes Identification Method Based on Multiple Classifier Integration

Predictive classification of Alzheimer’s disease using brain imaging and genetic data

may yield important insights into genetic influences on the biology of Alzheimer’s disease (AD).We investigated the accuracy of a novel unsuper- vised multimodal biomarker classifier for differentiating cognitively normal elderly (NC) from subjects with amnestic mild cognitive impairment

Alzheimer’s disease risk prediction using automated machine learning

Identification of immune microenvironment subtypes and signature genes for Alzheimer's disease diagnosis and risk prediction based on explainable machine learning

Application of artificial neural network model in diagnosis of Alzheimer’s disease

Multivariate Deep Learning Classification of Alzheimer’s Disease Based on Hierarchical Partner Matching Independent Component Analysis

Deep Learning-Based Polygenic Risk Analysis for Alzheimer’s Disease Prediction

A Machine Learning Method for Identifying Critical Interactions Between Gene Pairs in Alzheimer's Disease Prediction.

Predicting Alzheimer's Disease with Interpretable Machine Learning.

Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer’s Disease and Reconstruction of Relevant Biological Mechanisms